Press Releases

All Releases
View Summary Tekmira Announces Update to Its Proxy Circular on the Proposed Business Combination With OnCore Biopharma Inc.
Feb 25, 2015
PDF 13.2 KB Add to Briefcase
View Summary Tekmira to Present at RBC Capital Markets' Healthcare Conference
Feb 12, 2015
PDF 8.7 KB Add to Briefcase
View Summary Tekmira Announces Filing of Definitive Proxy Statement and Voluntary Delisting From the TSX
Feb 4, 2015
PDF 19.8 KB Add to Briefcase
View Summary Tekmira Initiates Phase I Clinical Trial of TKM-HBV
Jan 21, 2015
PDF 17.6 KB Add to Briefcase
View Summary Tekmira Pharmaceuticals and OnCore Biopharma Announce Merger Agreement to Create Leading Global Hepatitis B Virus Company
Jan 11, 2015
PDF 39.4 KB Add to Briefcase
View Summary Tekmira Provides Update on TKM-PLK1 Phase I/II Clinical Study in Patients With Advanced Gastrointestinal Neuroendocrine Tumors and Adrenocortical Carcinoma
Dec 31, 2014
PDF 60.9 KB Add to Briefcase
View Summary Tekmira Establishes Manufacturing and Clinical Trial Agreement to Provide TKM-Ebola-Guinea for Clinical Studies in West Africa
Dec 22, 2014
PDF 18.6 KB Add to Briefcase
View Summary Tekmira Receives Clearance to Conduct a Phase I Clinical Study With TKM-HBV
Dec 22, 2014
PDF 14.4 KB Add to Briefcase
View Summary Tekmira Pharmaceuticals Announces Leadership Changes
Dec 19, 2014
PDF 12.8 KB Add to Briefcase
View Summary Tekmira Files Shelf Registration Statement
Nov 26, 2014
PDF 13.2 KB Add to Briefcase
View Summary Tekmira Provides Key Highlights of Analyst and Investor Day in New York
Nov 21, 2014
PDF 14.6 KB Add to Briefcase
View Summary Tekmira Announces Licensing and Collaboration Agreement With Dicerna
Nov 17, 2014
PDF 17.6 KB Add to Briefcase
View Summary Tekmira to Present at Stifel Healthcare Conference
Nov 12, 2014
PDF 8.7 KB Add to Briefcase
View Summary Tekmira Provides Corporate Update and Announces Third Quarter 2014 Results
Nov 6, 2014
PDF 23.1 KB Add to Briefcase
View Summary Tekmira to Host Analyst Day on November 21 in New York City
Nov 5, 2014
PDF 9.0 KB Add to Briefcase
View Summary Tekmira Conference Call and Webcast Advisory: Corporate Update and Third Quarter Financial Results
Oct 23, 2014
PDF 9.0 KB Add to Briefcase
View Summary Tekmira Provides Periodic Update on TKM-Ebola Program
Oct 21, 2014
PDF 16.1 KB Add to Briefcase
View Summary Tekmira Presents Results of Preclinical Studies With Hepatitis B Therapeutic
Oct 15, 2014
PDF 18.1 KB Add to Briefcase
View Summary Tekmira's Partner Reports Positive Clinical Data for LNP-Enabled Patisiran
Oct 14, 2014
PDF 16.8 KB Add to Briefcase
View Summary Tekmira to Present HBV Pre-Clinical Data at Meeting of the Oligonucleotide Therapeutics Society
Oct 9, 2014
PDF 8.8 KB Add to Briefcase
Showing 1-20 of 256 Page: 1 2 3 4 5 ... 13  Next 20
Add to Briefcase = add release to Briefcase